eMedicine Specialties > Emergency Medicine > Gastrointestinal

Cholecystitis and Biliary Colic: Differential Diagnoses & Workup

Author: Rahul Sharma, MD, MBA, FACEP, Assistant Professor, Weill Medical College of Cornell University; Attending Physician, Department of Emergency Medicine, New York Presbyterian Hospital-Weill Cornell Medical Center
Coauthor(s): Peter A D Steel, MA, MBBS, Staff Physician, Department of Emergency Medicine, Joan and Sanford I Weill Medical College of Cornell and Columbia University College of Physicians and Surgeons, New York Presbyterian Hospitals
Contributor Information and Disclosures

Updated: Jul 28, 2009

Differential Diagnoses

Aneurysm, Abdominal
Myocardial Infarction
Cholangitis
Obstruction, Small Bowel
Cholelithiasis
Pancreatitis
Diverticular Disease
Pneumonia, Bacterial
Gastroenteritis
Pregnancy, Eclampsia
Hepatitis
Pregnancy, Hyperemesis Gravidarum
Herpes Zoster
Pregnancy, Urinary Tract Infections
Inflammatory Bowel Disease
Renal Calculi
Mesenteric Ischemia

Workup

Laboratory Studies

  • Labs with cholelithiasis and gallbladder colic should be completely normal. WBC, aspirate aminotransferase (AST), alanine aminotransferase (ALT), bilirubin, and alkaline phosphate may be helpful in the diagnosis of cholecystitis. However, presence of normal lab values does not exclude cholecystitis.
  • Because biliary obstruction is limited to the gallbladder in uncomplicated cholecystitis, elevation in the serum total bilirubin and alkaline phosphatase concentrations may not be present. A study by Singer et al examined the utility of laboratory values in acute cholecystitis diagnosed by hepatic 2,6-dimethyliminodiacetic acid (HIDA) scan.3 No difference was found in mean WBC, AST, ALT, bilirubin, and alkaline phosphate between patients diagnosed with cholecystitis and those without.
  • An elevated WBC is expected but not reliable. In a retrospective study, only 61% of patients with cholecystitis had a WBC greater than 11,000. A WBC greater than 15,000 may indicate perforation or gangrene.
  • Comprehensive metabolic panel with bicarbonate may exhibit the following:
    • AST, ALT, and alkaline phosphate levels may be elevated; however, as with other laboratory tests, these levels are not sensitive for excluding cholecystitis. When the AST and ALT are elevated significantly, a common bile duct stone is more likely.
    • An elevation of AST, ALT, or alkaline phosphate should raise the possibility of other biliary system pathology such as cholangitis, choledocholithiasis, or the Mirizzi syndrome (obstruction of the common bile duct by an impacted stone in the distal cystic duct).
    • Note calcium level (Ranson criteria) if evidence of biliary pancreatitis exists.
    • Other abnormalities (eg, renal insufficiency) are not related to cholecystitis but may indicate a comorbid condition.
  • Mild elevation of amylase up to 3 times normal may be found in cholecystitis, especially when gangrene is present.
  • Prothrombin time (PT) and activated partial thromboplastin time (aPTT) are not expected to be elevated unless sepsis or underlying cirrhosis is present. Coagulation profiles are helpful if the patient needs operative intervention.
  • For febrile patients, send 2 sets of blood cultures to attempt to isolate the organism in the presence of bacteremia from bacterial superinfection.
  • Although expected to be normal, urinalysis is essential in the workup of patients with abdominal pain to exclude pyelonephritis and renal calculi.
  • Conduct a pregnancy test for women of childbearing age.

Imaging Studies

  • Ultrasonography and nuclear medicine studies are the best imaging studies for the diagnosis of both cholecystitis and cholelithiasis. Ultrasonography is usually favored as the first test, whereas hepatobiliary scintigraphy is usually reserved for the 20% of patients in whom the diagnosis is unclear after ultrasonography has been performed. 
  •  Plain radiography, CT scans, and endoscopic retrograde cholangiopancreatography (ERCP) are diagnostic adjuncts.
  • Abdominal radiographs
    • The advantages of abdominal radiographs include their readily availability and low cost. However, abdominal radiographs have low sensitivity and specificity in evaluating biliary system pathology, but they can be helpful in excluding other abdominal pathology such as renal colic, bowel obstruction, perforation. Between 10 and 30% of stones have a ring of calcium and, therefore, are radiopaque. A porcelain gallbladder also may be observed on plain films.
    • Emphysematous cholecystitis, cholangitis, cholecystic-enteric fistula, or postendoscopic manipulation may show air in the biliary tree. Air in the gallbladder wall indicates emphysematous cholecystitis due to gas-forming organisms such as clostridial species and Escherichia coli.
  • Computed tomography scan
    • CT scan is not the test of choice and is recommended only for the evaluation of abdominal pain if the diagnosis is uncertain. CT scan can demonstrate gallbladder wall edema, pericholecystic stranding and fluid, and high-attenuation bile.
    • A helical CT scan with fine cuts through the biliary tract has not been well studied and may be useful.
    • Advantages: For complications of cholecystitis and cholangitis, gallbladder perforation, pericholecystic fluid, and intrahepatic ductal dilation, CT scan may be adequate. CT scan provides better information of the surrounding structures than sonogram and HIDA. CT scan is also noninvasive.
    • Disadvantages: CT scan misses 20% of gallstones because the stones may be of the same radiographic density as bile. CT scan is also more expensive and takes longer since the patient usually has to drink oral contrast. Also, given the radiation dose, it may not be ideal in the pregnant patient.
  • Ultrasonography


The ultrasound only shows gallstones within the g...

The ultrasound only shows gallstones within the gallbladder but no evidence of cholecystitis (ie, gallbladder wall thickening, pericholecystic fluid, common bile duct dilatation, sonographic Murphy sign).

The ultrasound only shows gallstones within the g...

The ultrasound only shows gallstones within the gallbladder but no evidence of cholecystitis (ie, gallbladder wall thickening, pericholecystic fluid, common bile duct dilatation, sonographic Murphy sign).

    • Ultrasonography is the most common test used in the ED for the diagnosis of biliary colic and acute cholecystitis. It is 90-95% sensitive for cholecystitis and 78-80% specific. For simple cholelithiasis, it is 98% sensitive and specific.
    • Ultrasonography may be diagnostic for biliary disease, help exclude biliary disease, or may reveal alternative causes of the patient's symptoms.
    • Findings include gallstones or sludge and one or more of the following conditions:
      • Gallbladder wall thickening (>2-4 mm) - False-positive wall thickening found in hypoalbuminemia, ascites, congestive heart failure, and carcinoma
      • Gallbladder distention (diameter > 4 cm, length >10 cm)
      • Pericholecystic fluid from perforation or exudate may be seen as a hypoechoic or anechoic region seen along the anterior surface of the gallbladder within the hepatic parenchyma.
      • Air in the gallbladder wall (indicating gangrenous cholecystitis)
      • Sonographic Murphy sign (86-92% sensitive, 35% specific), pain when the probe is pushed directly on the gallbladder (not related to breathing)
    • Some ED sonographers recommend the diagnosis of cholecystitis if both a sonographic Murphy sign and gallstones (without evidence of other pathology) are present.
    • In a study by Ralls et al, involving 497 patients with suspected acute cholecystitis, the positive predictive value of the presence of stones and a positive ultrasonographic Murphy's sign was 92%, and that of stones and thickening of the gallbladder wall was 95%. The negative predictive value of the absence of stones combined with either a normal gallbladder wall or a negative Murphy's sign was 95%.4
    • Additional findings in the presence or absence of gallstones: Dilated common bile duct or dilated intrahepatic ducts of the biliary tree indicate common bile duct stones. In the absence of stones, a solitary stone may be lodged in the common bile duct, a location difficult to visualize sonographically.
    • Advantages of sonography include the following:
      • Images other structures (eg, aorta, pancreas, liver)
      • Identifies complications (eg, perforation, empyema, abscess)
      • Rapidly performed at the bedside and by the ED physician (see Bedside Ultrasonography, Gallbladder Disease)
      • No radiation (important in pregnancy)
    • Disadvantages of sonography include the following:
      • Operator dependent and patient dependent
      • Inability to image the cystic duct
      • Decreased sensitivity for common bile duct stones
  • Biliary scintigraphy (HIDA, diisopropyl iminodiacetic acid [DISIDA]), nuclear medicine studies
    • Depending on the ED, either sonography or nuclear medicine testing is the test of choice for cholecystitis. HIDA scans have sensitivity (94%) and specificity (65-85%) for acute cholecystitis. They are sensitive (65%) and specific (6%) for chronic cholecystitis. Oral cholecystography is not practical for the ED.
    • HIDA and DISIDA scans are functional studies of the gallbladder. Technetium-labeled analogues of iminodiacetic acid (IDA) or diisopropyl IDA-DISIDA are administered intravenously (IV) and secreted by hepatocytes into bile, enabling visualization of the liver and biliary tree.
    • Normal scans are characterized by normal visualization of gallbladder in 30 minutes.
    • With cystic duct obstruction (cholecystitis), the HIDA scan shows nonvisualization (ie, considered positive) of the gallbladder at 60 minutes and uptake in the intestine as the bile is excreted directly into the duodenum. This finding has a sensitivity of 80-90% for acute cholecystitis.
    • Obstruction of the common bile duct causes nonvisualization of the small intestine.
    • The rim sign is a blush of increased pericholecystic radioactivity, tracer adjacent to the gallbladder, present in approximately 30% of patients with acute cholecystitis and in 60% with acute gangrenous cholecystitis.
    • False-negative results (filling in 30 min) are found in 0.5% of studies, and filling between 30-60 minutes is associated with false-negative rates of 15-20%.
    • False-positive results (10-20%) occur when the gallbladder does not visualize despite a nonobstructed cystic duct. Causes include fasting patients receiving total parenteral nutrition; severe liver disease, which leads to abnormal uptake of the tracer; cystic-duct obstruction induced by chronic inflammation, and biliary sphincterotomy, which decreases resistance to bile flow leading to excretion of the tracer into the duodenum. The specificity of the test can be improved by intravenous administration of morphine, known as morphine cholescintigraphy, which induces spasm of this sphincter, increasing back pressure to fill the gallbladder.5
    • Advantages of HIDA/DISIDA scans include the following:
      • Assessment of function
      • Normal-appearing gallbladder (by ultrasound); obstructed cystic duct abnormal on DISIDA scan but not ultrasound.
      • Simultaneous assessment of bile ducts
    • Disadvantages of HIDA/DISIDA scans include the following:
      • High bilirubin (>4.4 mg/dL) possibly decreases sensitivity
      • Recent eating or fasting for 24 hours also possibly affects study
      • No imaging of other structures in the area

Other Tests

  • Endoscopic retrograde cholangiopancreatography
    • ERCP provides both endoscopic and radiographic visualization of the biliary tract. It can be diagnostic and therapeutic by direct removal of common bile duct stones.
    • Ultrasound is 50-75% sensitive for choledocholithiasis. CT and HIDA scans are not better. Therefore, when a dilated common bile duct is found or elevated LFTs are present, suspicion should remain high for common bile duct stones, and an ERCP should be considered.
    • Debate exists as to when an ERCP should be performed. In general, since cholecystitis is caused by obstruction of the ducts, the risk of common bile duct stones is approximately 10%. Given its potential for complications, ERCP should be used when there is a high potential for intervention and it should not be used solely as a diagnostic modality.
    • Some studies have classified people as low risk for common bile duct stones based on (1) lack of jaundice, (2) elevated transaminases, and (3) a common bile duct diameter of less than 8 mm. In this population, the risk of common bile duct stones may be as low as 1%. In patients with any of the risk factors, the rate of stones was 39%. Therefore, in general, people with any of the risk factors for common bile duct stones should undergo operative or ERCP evaluation of the common bile duct.
    • Major complications of ERCP include pancreatitis and cholangitis.

More on Cholecystitis and Biliary Colic

Overview: Cholecystitis and Biliary Colic
Differential Diagnoses & Workup: Cholecystitis and Biliary Colic
Treatment & Medication: Cholecystitis and Biliary Colic
Follow-up: Cholecystitis and Biliary Colic
Multimedia: Cholecystitis and Biliary Colic
References

References

  1. Carter HR, Cox RL, Polk HC Jr. Operative therapy for cholecystitis and cholelithiasis: trends over three decades. Am Surg. Oct 1987;53(10):565-8. [Medline].

  2. Urbach DR, Stukel TA. Rate of elective cholecystectomy and the incidence of severe gallstone disease. CMAJ. Apr 12 2005;172(8):1015-9. [Medline].

  3. Singer AJ, McCracken G, Henry MC, et al. Correlation among clinical, laboratory, and hepatobiliary scanning findings in patients with suspected acute cholecystitis. Ann Emerg Med. Sep 1996;28(3):267-72. [Medline].

  4. Ralls PW, Colletti PM, Lapin SA, Chandrasoma P, Boswell WD Jr, Ngo C. Real-time sonography in suspected acute cholecystitis. Prospective evaluation of primary and secondary signs. Radiology. Jun 1985;155(3):767-71. [Medline].

  5. Kim CK, Tse KK, Juweid M, Mozley PD, Woda A, Alavi A. Cholescintigraphy in the diagnosis of acute cholecystitis: morphine augmentation is superior to delayed imaging. J Nucl Med. Nov 1993;34(11):1866-70. [Medline].

  6. [Guideline] Hirota M, Takada T, Kawarada Y, Nimura Y, Miura F, Hirata K. Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg. 2007;14(1):78-82. [Medline].

  7. [Guideline] Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis. Oct 15 2003;37(8):997-1005. [Medline].

  8. Strasberg SM. Clinical practice. Acute calculous cholecystitis. N Engl J Med. Jun 26 2008;358(26):2804-11. [Medline].

  9. Adedeji OA, McAdam WA. Murphy's sign, acute cholecystitis and elderly people. J R Coll Surg Edinb. Apr 1996;41(2):88-9. [Medline].

  10. Morrow DJ, Thompson J, Wilson SE. Acute cholecystitis in the elderly: a surgical emergency. Arch Surg. Oct 1978;113(10):1149-52. [Medline].

  11. American College of Emergency Physicians. Emergency ultrasound imaging criteria compendium. Ann Emerg Med. Oct 2006;48(4):487-510. [Medline].

  12. Bennett GL, Balthazar EJ. Ultrasound and CT evaluation of emergent gallbladder pathology. Radiol Clin North Am. Nov 2003;41(6):1203-16. [Medline].

  13. Burrell MI, Zeman RK, Simeone JF, et al. The biliary tract: imaging for the 1990s. AJR Am J Roentgenol. Aug 1991;157(2):223-33. [Medline].

  14. Flasar MH, Cross R, Goldberg E. Acute abdominal pain. Prim Care. Sep 2006;33(3):659-84, vi. [Medline].

  15. Giurgiu DI, Roslyn JJ. Treatment of gallstones in the 1990s. Prim Care. Sep 1996;23(3):497-513. [Medline].

  16. Gruber PJ, Silverman RA, Gottesfeld S, Flaster E. Presence of fever and leukocytosis in acute cholecystitis. Ann Emerg Med. Sep 1996;28(3):273-7. [Medline].

  17. Houdart R, Perniceni T, Darne B, et al. Predicting common bile duct lithiasis: determination and prospective validation of a model predicting low risk. Am J Surg. Jul 1995;170(1):38-43. [Medline].

  18. Janowitz P, Kratzer W, Zemmler T, et al. Gallbladder sludge: spontaneous course and incidence of complications in patients without stones. Hepatology. Aug 1994;20(2):291-4. [Medline].

  19. Kim MK, Strait RT, Sato TT, Hennes HM. A randomized clinical trial of analgesia in children with acute abdominal pain. Acad Emerg Med. Apr 2002;9(4):281-7. [Medline].

  20. McHale PM, LoVecchio F. Narcotic analgesia in the acute abdomen--a review of prospective trials. Eur J Emerg Med. Jun 2001;8(2):131-6. [Medline].

  21. McSherry CK, Ferstenberg H, Calhoun WF, et al. The natural history of diagnosed gallstone disease in symptomatic and asymptomatic patients. Ann Surg. Jul 1985;202(1):59-63. [Medline].

  22. Moscati RM. Cholelithiasis, cholecystitis, and pancreatitis. Emerg Med Clin North Am. Nov 1996;14(4):719-37. [Medline].

  23. Saini S. Imaging of the hepatobiliary tract. N Engl J Med. Jun 26 1997;336(26):1889-94. [Medline].

  24. Shea JA, Berlin JA, Escarce JJ. Revised estimates of diagnostic test sensitivity and specificity in suspected biliary tract disease. Arch Intern Med. Nov 28 1994;154(22):2573-81. [Medline].

  25. Stevens KA, Chi A, Lucas LC, Porter JM, Williams MD. Immediate laparoscopic cholecystectomy for acute cholecystitis: no need to wait. Am J Surg. Dec 2006;192(6):756-61. [Medline].

  26. Strasberg SM, Clavien PA. Overview of therapeutic modalities for the treatment of gallstone diseases. Am J Surg. Apr 1993;165(4):420-6. [Medline].

  27. Swisher SG, Schmit PJ, Hunt KK, et al. Biliary disease during pregnancy. Am J Surg. Dec 1994;168(6):576-9; discussion 580-1. [Medline].

  28. Tait N, Little JM. The treatment of gall stones. BMJ. Jul 8 1995;311(6997):99-105. [Medline].

  29. Talley NJ. Gallstones and upper abdominal discomfort. Innocent bystander or a cause of dyspepsia?. J Clin Gastroenterol. Apr 1995;20(3):182-3. [Medline].

  30. Thomas SH, Borczuk P, Shackelford J. Patient and physician agreement on abdominal pain severity and need for opioid analgesia. Am J Emerg Med. Oct 1999;17(6):586-90. [Medline].

  31. Thomas SH, Silen W. Effect on diagnostic efficiency of analgesia for undifferentiated abdominal pain. Br J Surg. Jan 2003;90(1):5-9. [Medline].

  32. Thomas SH, Silen W, Cheema F. Effects of morphine analgesia on diagnostic accuracy in Emergency Department patients with abdominal pain: a prospective, randomized trial. J Am Coll Surg. Jan 2003;196(1):18-31. [Medline].

  33. Traverso LW. Clinical manifestations and impact of gallstone disease. Am J Surg. Apr 1993;165(4):405-9. [Medline].

  34. Tsimoyiannis EC, Antoniou NC, Tsaboulas C, Papanikolaou N. Cholelithiasis during pregnancy and lactation. Prospective study. Eur J Surg. Nov 1994;160(11):627-31. [Medline].

  35. Yusoff IF, Barkun JS, Barkun AN. Diagnosis and management of cholecystitis and cholangitis. Gastroenterol Clin North Am. Dec 2003;32(4):1145-68. [Medline].

  36. Zeman RK, Garra BS. Gallbladder imaging. The state of the art. Gastroenterol Clin North Am. Mar 1991;20(1):127-56. [Medline].

Further Reading

Contributor Information and Disclosures

Author

Rahul Sharma, MD, MBA, FACEP, Assistant Professor, Weill Medical College of Cornell University; Attending Physician, Department of Emergency Medicine, New York Presbyterian Hospital-Weill Cornell Medical Center
Rahul Sharma, MD, MBA, FACEP is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.

Coauthor(s)

Peter A D Steel, MA, MBBS, Staff Physician, Department of Emergency Medicine, Joan and Sanford I Weill Medical College of Cornell and Columbia University College of Physicians and Surgeons, New York Presbyterian Hospitals
Peter A D Steel, MA, MBBS is a member of the following medical societies: American College of Emergency Physicians, British Medical Association, Emergency Medicine Residents Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Medical Editor

Samuel M Keim, MD, Associate Professor, Department of Emergency Medicine, University of Arizona College of Medicine
Samuel M Keim, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Public Health Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Eugene Hardin, MD, FAAEM, FACEP, Former Chair and Associate Professor, Department of Emergency Medicine, Charles Drew University of Medicine and Science; Former Chair, Department of Emergency Medicine, Martin Luther King Jr/Drew Medical Center
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Barry E Brenner, MD, PhD, FACEP, Professor of Emergency Medicine, Professor of Internal Medicine, Program Director, Emergency Medicine, University Hospitals, Case Medical Center
Barry E Brenner, MD, PhD, FACEP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Chest Physicians, American College of Emergency Physicians, American College of Physicians, American Heart Association, American Thoracic Society, Arkansas Medical Society, New York Academy of Medicine, New York Academy of Sciences, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.